SUPERNUS PHARMACEUTICALS, INC. (NASDAQ:SUPN) filed a Form 8-K with the Securities and Exchange Commission on January 28, 2026, disclosing a material event.
SUPERNUS PHARMACEUTICALS, INC.'s stock currently trades at $48.94 with a market capitalization of $2.6B. The Healthcare company's stock moved following the disclosure.